GlaxoSmithKline (GSK) Fails to deliver data

Key failure to deliver metrics for GlaxoSmithKline:

• Last SEC data release: 2024-10-31
• Last 15 days FTD volume: A$1.44 M
• Last 3 months FTD volume: A$25.89 M
• Last year FTD volume: A$25.89 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for GlaxoSmithKline (GSK) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for GlaxoSmithKline (GSK) - since 2022

GlaxoSmithKline (GSK) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
AstraZeneca AZN	A$31.61 M	A$0.16 B	🇬🇧 UK
Pfizer PFE	A$50.21 M	A$0.38 B	🇺🇸 USA
Merck MRK	A$14.45 M	A$88.44 M	🇺🇸 USA
Novartis NVS	A$22.57 M	A$74.81 M	🇨🇭 Switzerland
Sanofi SNY	A$11.64 M	A$71.88 M	🇫🇷 France
Teva Pharmaceutical Industries TEVA	A$9.38 M	A$32.19 M	🇮🇱 Israel
Dynavax Technologies DVAX	A$8.39 M	A$32.61 M	🇺🇸 USA